AlphaFold predicted structure
SLC6A19 · Q695T7

Mean pLDDT
90.0/ 100
Very high
634 residues
Confidence breakdown
- Very high(≥ 90)75%
- Confident(70–90)21%
- Low(50–70)2%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 6 member 19
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Intellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
COVID-19 research
UnknownEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalNephrocalcinosis or nephrolithiasis
BIALLELIC, autosomal or pseudoautosomalHartnup disease
iminoglycinuria
Hyperglycinuria
clonal hematopoiesis
frozen shoulder
hereditary disease
pathological myopia
myopia
colorectal carcinoma
nonpapillary renal cell carcinoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium-dependent neutral amino acid transporter B(0)AT1
Transporter that mediates resorption of neutral amino acids across the apical membrane of renal and intestinal epithelial cells (PubMed:15286787, PubMed:15286788, PubMed:18424768, PubMed:18484095, PubMed:19185582, PubMed:26240152). This uptake is sodium-dependent and chloride-independent (PubMed:15286787, PubMed:15286788, PubMed:19185582). Requires CLTRN in kidney or ACE2 in intestine for cell surface expression and amino acid transporter activity (PubMed:18424768, PubMed:19185582)
SLC6A19 · Q695T7

Mean pLDDT
90.0/ 100
Very high
634 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0